Ipca Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
February 14, 2024 at 03:09 am EST
Share
Ipca Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 20,528.6 million compared to INR 15,460 million a year ago. Revenue was INR 20,753.1 million compared to INR 15,768.9 million a year ago. Net income was INR 1,798.8 million compared to INR 1,078.4 million a year ago. Basic earnings per share from continuing operations was INR 7.09 compared to INR 4.25 a year ago. Diluted earnings per share from continuing operations was INR 7.09 compared to INR 4.25 a year ago.
For the nine months, sales was INR 56,720.3 million compared to INR 47,326.9 million a year ago. Revenue was INR 57,778.8 million compared to INR 48,219.2 million a year ago. Net income was INR 4,877.6 million compared to INR 3,948 million a year ago. Basic earnings per share from continuing operations was INR 19.23 compared to INR 15.56 a year ago. Diluted earnings per share from continuing operations was INR 19.23 compared to INR 15.56 a year ago.
Ipca Laboratories Limited is an India-based pharmaceutical company. The Company is manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The products of the Company are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIâs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd and Tonira Exports Limited.